Publication | Closed Access

Endoxifen is a new potent inhibitor of PKC: A potential therapeutic agent for bipolar disorder

PsychiatryPotential Therapeutic AgentMedicineDrug DiscoveryPsychotropic MedicationDepressionPsychopharmacologyNeuropharmacologyPharmacotherapyBiological PsychiatryPharmacologyNew Potent InhibitorBipolar DisorderTranslational Pharmacology